TLR4 and breast cancer: Kashani B et al. used the small molecule inhibitor of TLR4 (TAK-242—Resatorvid) in mouse models of ovarian and breast cancer, and found that TAK-242 halted cancer cell proliferation by inducing cell cycle arrest and apoptosis through the modulation of genes involved in these processes [108].